首頁 > 市場調查報告書 > 製藥

自體免疫疾病

市場調查報告書

商品編碼

1820236

2025 年至 2033 年免疫調節劑市場報告（按產品（免疫抑制劑、免疫促效劑）、應用（腫瘤學、呼吸系統疾病、愛滋病毒等）和地區分類）

Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024 年全球免疫調節劑市場規模達 2,217 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 3,391 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.8%。

免疫調節劑是一類用於調節免疫反應以對抗傳染病、免疫缺陷和抗體轉移改變的藥物。這類藥物通常包括單株抗體、細胞激素、左旋咪唑和卡介苗 (BCG)。它們被廣泛用於治療癌症、氣喘、腫瘤、遺傳性血管性水腫以及天皰瘡、狼瘡、過敏和類風濕性關節炎等自體免疫疾病。如今，一些醫療保健提供者建議將免疫調節劑與其他藥物（例如生物製劑）聯合用於治療發炎性腸道疾病 (IBD)。

免疫調節劑市場趨勢：

快速城市化、收入水平膨脹以及加工食品消費的增加導致人們的生活方式不健康，導致全球慢性病盛行率顯著上升。這進一步增加了器官移植的需求，從而對局部免疫調節劑的需求產生了積極影響，因為局部免疫調節劑是器官移植接受者的一種有前景的治療藥物。此外，老化人口的增加和事故數量的增加也增加了器官衰竭的風險。因此，一些政府和非政府機構都在鼓勵器官捐贈，這反過來又推動了全球局部免疫調節劑的銷售。此外，發炎性腸道疾病 (IBD) 和自體免疫疾病的盛行率不斷上升也促進了市場的成長。免疫調節劑也用於合併治療，以減少對類固醇的長期需求，預防復發性發作，並治療對抗生素無效的疾病。此外，包括氟伏沙明、托珠單抗以及巴瑞替尼和瑞德西韋在內的多種免疫調節劑正在用於治療新冠肺炎住院患者。此外，目前還有幾種候選產品處於後期臨床試驗階段。這些產品的開發預計將擴大免疫調節劑在治療各種危及生命的疾病的應用。

本報告回答的關鍵問題：

全球免疫調節劑市場迄今表現如何？未來幾年將如何表現？
COVID-19 對全球免疫調節劑市場有何影響？
主要的區域市場有哪些？
根據產品，市場是如何分類的？
根據應用，市場是如何分類的？
該產業的價值鏈分為哪些階段？
該行業的主要促進因素和挑戰是什麼？
全球免疫調節劑市場的結構是怎麼樣的？主要參與者是誰？
產業競爭程度如何？

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

Breakup by Product:

Immunosuppressants
- Antibodies
- Calcineurin Inhibitors
- Glucocorticoids
- Antimetabolites
- Others
Immunostimulants
- Vaccines
- Antibodies
- Others

Breakup by Application:

Oncology
Respiratory
HIV
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Key Questions Answered in This Report:

How has the global immunomodulators market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunomodulators market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunomodulators market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Immunomodulators Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Immunosuppressants
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Antibodies
  - 6.1.2.2 Calcineurin Inhibitors
  - 6.1.2.3 Glucocorticoids
  - 6.1.2.4 Antimetabolites
  - 6.1.2.5 Others
- 6.1.3 Market Forecast
6.2 Immunostimulants
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Vaccines
  - 6.2.2.2 Antibodies
  - 6.2.2.3 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Oncology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Respiratory
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 HIV
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Amgen Inc.
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Biogen Inc.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 Bristol-Myers Squibb Company
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Eli Lilly and Company
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 F. Hoffmann-La Roche AG
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 SWOT Analysis
- 13.3.6 Johnson & Johnson
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
  - 13.3.6.4 SWOT Analysis
- 13.3.7 Merck & Co. Inc.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Novartis AG
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Pfizer Inc.
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
Figure 2: Global: Immunomodulators Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2024
Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2024
Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2024
Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: North America: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: United States: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Canada: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: China: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Japan: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: India: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Australia: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Others: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Europe: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Germany: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: France: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Italy: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Spain: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Russia: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Others: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2024
Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Global: Immunomodulators Industry: SWOT Analysis
Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Immunomodulators Market: Competitive Structure
Table 6: Global: Immunomodulators Market: Key Players

02-2729-4219

+886-2-2729-4219